Members of the NYU Cancer Institute’s Board of Advisors support the clinical, research, educational, and community outreach goals of the NYUCI by serving as ambassadors among their friends and colleagues, raising funds, and ﬁnancially supporting the Cancer Institute’s mission. The NYUCI has announced the appointment of the following new Board members:
Norman M. Feinberg is President and Chief Executive of the Gateside Corporation, a commercial and residential real estate development and investment company. He has acquired and developed apartment, ofﬁce, and industrial buildings in several states, and built one of the largest marinas in the country. He also has substantial business interests in France.
In 2011, Mr. Feinberg and his wife, Arline, contributed $1 million to support translational research related to lymphoma. Mr. Feinberg was treated at the NYUCI for lymphoma in 2009. “Having experienced ﬁrsthand the dedication and excellence of the NYU Cancer Institute, I am pleased to continue my support by becoming a member of the Advisory Board,” he said.
Mr. Feinberg is a graduate of New York University and has long been involved in philanthropic causes.
Celeste Guth is a Vice Chairman and has global responsibility for the Financial Institutions Group in the Investment Banking Division of Goldman Sachs. She joined Goldman Sachs in 1986, became a Vice President in 1990, and was named Managing Director in 1997 and Partner in 2002.
She was treated at the NYU Cancer Institute in 2007 and 2011. “When I was a patient at the NYU Clinical Cancer Center, I was impressed with the level of care and the compassion of everyone on my healthcare team,” says Ms. Guth. “Serving on the Board of Advisors is my way of giving back to this extraordinary institution.”
Ms. Guth graduated from Queens College of the City University of New York in 1982 and earned an MBA from Harvard Business School in 1986.